CDKN1B and cancer: Several mechanisms have been proposed to explain how proteasome inhibition leads to cell death of cancer cells, including stabilization of the pro-apoptotic proteins p27KIP1, p53 and Bax, defective nuclear factor-kB activation, decreased interleukin-6 signalling and induction of oxidative and endoplasmic reticulum stress [107, 108].